Market Research Trends

In 2022, the global generic oncology drugs market size was valued at US$ 24.5 billion. It is projected to grow at a compound annual growth rate (CAGR) of 6% between 2022 and 2028, ultimately exceeding US$ 34.8 billion by the end of 2028. The primary cause of cancer is the increasing prevalence of smoking and tobacco consumption, while secondary factors such as sedentary lifestyles, genetic causes, viral infections, carcinogens, and high consumption of unhealthy foods make individuals more vulnerable to cancer. Governments are taking proactive measures to prevent cancer due to concerns over the high number of cancer-related deaths. The healthcare industry widely uses generic oncology drugs to detect and treat tumors. Technological advancements, particularly the integration of information technology, are expected to drive growth in the generic oncology drugs market and reduce the cost of cancer treatment. Real-world data, mobile applications, and artificial intelligence are some of the ...

The global Generic Oncology Pharmaceuticals Market was valued at $24.5 billion in 2022 and is expected to grow at a 6% CAGR between 2022 and 2028, reaching more than $34.8 billion by the end of 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food make the human body susceptible to cancer. Growing concerns of a high number of deaths occurring on the back of cancer have provoked the government authorities to take effective steps for preventing cancer. Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. A...